elsevier – Retraction Watch

Editors of economics journal resign after Elsevier doesn’t renew EIC’s contract

Six editors and nearly 60 advisory editors of Games and Economic Behavior resigned after the journal’s publisher decided not to renew the editor-in-chief’s contract.

In late July, Elsevier told Hervé Moulin, a business professor of the University of Glasgow, his six-year tenure as editor-in-chief of the journal would end in December. Moulin told Retraction Watch he was disappointed by the news, as he had expressed a desire to continue in his role.

The journal’s six editors resigned in the weeks following, according to an August 16 email, the text of which is also posted on the website for the Game Theory Society. Games and Economic Behavior is one of the group’s two official journals. As of August 19, 58 of the 62 advisory editors had resigned as well.

Defamation suit demanding Elsevier retract paper heads closer to trial

A trial date has been set in a $1 billion defamation case against Elsevier that alleges the company published what plaintiffs say was a manipulated study about an air purifying technology over objections from peer reviewers. The case has already cost Elsevier a $10,000 sanction from a judge.

Global Plasma Solutions (GPS), which makes air quality products, sued Elsevier in 2022 after the publisher declined to retract a 2021 paper in Building and Environment about GPS’ needlepoint bipolar ionization technology, which it heavily marketed during the COVID-19 pandemic as an air purifier. The complaint claims Elsevier is responsible for the authors’ alleged omission of data and misleading conclusions in the paper that fueled “massive” financial losses for the company, its lawyers claim. Elsevier knew the paper “failed peer review” under its “own standards,” but moved forward with the article despite this knowledge, according to GPS, which now goes by GPS Air.

The complaint has survived a bid by Elsevier to dismiss the case, and a trial has been set for Dec. 7. In allowing the case to proceed, U.S. Magistrate Judge David Keesler said in a May 2024 opinion that GPS has “plausibly alleged actual malice” by Elsevier defined as “knowledge of falsity or reckless disregard for the truth.” Chief Judge Martin Reidinger of the U.S. District Court for the Western District of North Carolina upheld Keesler’s recommendation in July 2025.

Ceramics journal pulls dozens of papers flagged for integrity concerns

A materials science journal has pulled 56 papers so far this year for transgressions including image overlap, concerns about data integrity and “suspicious” changes in authorship.

Ceramics International began retracting the papers in July. More than 50 of the retractions were requested by an “impartial field expert acting in the role of an independent Publishing Ethics advisor,” according to the notices.

Most of the retraction notices – 43 – reference PubPeer comments calling out issues with the work. In emails we have seen, scientific sleuth Mu Yang flagged 80 papers from Ceramics International to the journal’s publisher, Elsevier, on April 23, 2025.

Clarivate removes hold on mega-journal Heliyon after internal audit, 650+ retractions

Clarivate has lifted its hold on Heliyon after the journal’s internal audit led to over 1,000 retractions, expressions of concern and corrections. As a result, the journal will receive an impact factor in the coming cycle, a Clarivate spokesperson said.

Clarivate decided in September 2024 new content from Heliyon would not be indexed in its Web of Science due to concerns about quality. The journal told us at the time it was “investigating,” and since then, it has retracted over 650 articles.

Clarivate lifted the hold on May 14, and Heliyon released a statement shortly after, noting all content published while the journal was on hold will now be indexed. The statement says the audit “revealed behaviors that did not align with our policies.” As we wrote in February, the journal has previously said the concerning practices included compromised peer review, authorship irregularities, tortured phrases and citation manipulation.

High-profile anesthesiologists earning retractions for data, image problems

In July 2021, John Loadsman received a manuscript about a clinical trial that immediately roused his suspicion. Then the editor-in-chief of Anaesthesia and Intensive Care, Loadsman asked the authors for the raw data.

They weren’t pretty. “When I looked carefully at the spreadsheet, I could see entire blocks of data that were repeated,” recalled Loadsman, an anesthesiologist and scientific sleuth at the University of Sydney. “It was obvious that this was cooked.”

He rejected the manuscript, informing both the corresponding author, Reyhan Polat of the University of Health Sciences in Ankara and Etlik City Hospital, in Turkey, and her institution about his concerns. He also made a mental note to have a look at the researcher’s published work. Over the following years, that effort drew in another sleuth and eventually prompted inquiries into more than two dozen papers by a network of researchers in Turkey.

Federal lawsuit accuses four major publishers of extorting article processing charges

A lawsuit filed under the U.S. False Claims Act accuses four major publishers of perpetrating a decade-long scheme to defraud the government by charging exorbitant article processing charges.

The case, which became unsealed July 30, claims Elsevier, Springer Nature, Wiley and Informa forced U.S. research institutions to submit false claims to the government for reimbursement through article fees up to 10 times the cost of processing the articles.

Juan Pablo Alperin, a professor at Simon Fraser University and codirector of the Scholarly Communications Lab based in Vancouver, is represented by two attorneys who have had blockbuster success in FCA cases over the past decade. He and his attorneys originally filed the case under seal in March 2024. The government declined to intervene in the case on July 23 of this year, and a judge ordered the complaint unsealed, which now allows Alperin to pursue the case independently.

Journal investigating apparent data mismatch in climate study

A leading environmental economics journal is looking into claims that a 2025 study linking national innovation to lower carbon emissions contains data that does not match its source, after an expert in the field requested the paper be retracted.

The article appeared in Ecological Economics, the journal for the International Society for Ecological Economics and published by Elsevier. The authors, three researchers at ESSCA School of Management in Lyon, claimed to draw on data from 229 countries between 2013 and 2020 and reported a negative relationship between a country’s “innovativeness” and its carbon dioxide emissions per capita. The paper has been cited five times, according to Clarivate’s Web of Science.

But three months after it was published, in October 2025, the journal began investigating anomalies in the dataset, although the authors maintain none of it was fabricated. In a letter to the journal’s editors requesting a retraction last October, seen by Retraction Watch, an academic with expertise in the field who reviewed the dataset said the paper had “serious data integrity concerns” and described a “clear case of research misconduct.”

Increasing workload may have contributed to recent retraction at nursing journal, editor says

Roger Watson was seeking answers. Last September, a paper in his journal had attracted criticism he thought he and his fellow editors at Nurse Education in Practice should have caught.

The February 2025 paper described the role of moulage, or simulated, realistic-looking wounds, in training nurses to perform endotracheal suction, a way of clearing out the lungs. One group used dummies with simulated bodily fluids, and the other group used regular dummies. An expert flagged the paper seven months after it was published: Tubes used in groups with or without moulage dummies had “significant size difference, which may have influenced the level of difficulty for participants to complete the suctioning task,” the expert wrote in an email Retraction Watch has seen.

The authors responded to the concerns at first, but then the conversation reached an impasse, the authors stopped responding, and the only choice, Watson said, was to retract the paper.

Elsevier retracts study tying sudden infant death syndrome to vaccinations

Elsevier has retracted a 2021 study claiming sudden infant death syndrome is linked to vaccines over concerns the paper might influence patient care.

The single-author study, by longtime vaccine critic Neil Z. Miller and published in Toxicology Reports, found 75 percent of SIDS cases reported occurred within seven days of vaccination, suggesting the fatalities are tied to immunizations. In an April 9 notice, Elsevier said it initiated an investigation into the paper after concerns arose from readers about potential research errors and methodological flaws.

According to the removal notice, editor-in-chief Lawrence H. Lash determined the author’s response did not “satisfactorily address” the concerns, particularly, the “serious methodological flaws” in using the Vaccine Adverse Event Reporting System (VAERS) to infer a correlation between vaccination and SIDS.

Elsevier journal removes two 42-year-old papers on cesium as a cancer treatment

An Elsevier journal has removed two papers on a discredited alternative treatment for cancer nearly half a century after they were published, after researchers found a quarter of patients in case reports of the therapy, cesium chloride, died from taking the substance.

Some alternative medicine advocates marketed cesium chloride as a cancer treatment in the 1980s and 1990s, although the risks and ineffectiveness of the therapy have been known for decades. In 2018, the U.S. Food and Drug Administration issued a warning about “significant safety risks” associated with the salt.

Marcel van der Heyden, a professor at the University Medical Center Utrecht in The Netherlands, told Retraction Watch he and his students came across the articles while writing a review of case reports on the use of cesium. Although the therapy was supported online and in health books, he said, all pointed to two 1984 papers in Pharmacology Biochemistry and Behavior: “Cesium therapy in cancer patients” by Hellfried Sartori and “The high pH therapy for cancer tests on mice and humans” by Aubrey Keith Brewer.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: